Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 242


Long-term outcomes of patients with end-stage kidney disease due to membranous nephropathy: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry.

Yang WL, Bose B, Zhang L, Mcstea M, Cho Y, Fahim M, Hawley CM, Pascoe EM, Johnson DW.

PLoS One. 2019 Aug 23;14(8):e0221531. doi: 10.1371/journal.pone.0221531. eCollection 2019.


Haemodialysis withdrawal in Australia and New Zealand: a binational registry study.

Chan S, Marshall MR, Ellis RJ, Ranganathan D, Hawley CM, Johnson DW, Wolley MJ.

Nephrol Dial Transplant. 2019 Aug 9. pii: gfz160. doi: 10.1093/ndt/gfz160. [Epub ahead of print]


Identifying critically important vascular access outcomes for trials in haemodialysis: an international survey with patients, caregivers and health professionals.

Viecelli AK, Howell M, Tong A, Teixeira-Pinto A, O'Lone E, Ju A, Craig JC, Hooi LS, Lee T, Lok CE, Polkinghorne KR, Quinn RR, Vachharajani TJ, Vanholder R, Zuo L, Tordoir J, Pecoits-Filho R, Yuo T, Kopperschmidt P, Smith R, Irish AB, Mori TA, Pascoe EM, Johnson DW, Hawley CM.

Nephrol Dial Transplant. 2019 Aug 1. pii: gfz148. doi: 10.1093/ndt/gfz148. [Epub ahead of print]


Identifying geospatial "hot spots" of glomerular diseases: opportunities and challenges.

Hawley CM, Pascoe EM.

Kidney Int. 2019 Aug;96(2):277-280. doi: 10.1016/j.kint.2019.04.036.


Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis study.

Zhan Z, Smyth B, Toussaint ND, Gray NA, Zuo L, de Zoysa JR, Chan CT, Jin C, Scaria A, Hawley CM, Perkovic V, Jardine MJ, Zhang L.

BMC Nephrol. 2019 Jul 12;20(1):258. doi: 10.1186/s12882-019-1438-3.


Principles and strategies for involving patients in research in chronic kidney disease: report from national workshops.

Gutman T, Tong A, Howell M, Dansie K, Hawley CM, Craig JC, Jesudason S, Chapman JR, Johnson DW, Murphy L, Reidlinger D, Crowe S, Duncanson E, Muthuramalingam S, Scholes-Robertson N, Williamson A, McDonald S; Better Evidence and Translation in Chronic Kidney Disease (BEAT-CKD) Workshop Investigators .

Nephrol Dial Transplant. 2019 May 15. pii: gfz076. doi: 10.1093/ndt/gfz076. [Epub ahead of print]


Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial.

Viecelli AK, Polkinghorne KR, Pascoe EM, Paul-Brent PA, Hawley CM, Badve SV, Cass A, Hooi LS, Kerr PG, Mori TA, Ong LM, Voss D, Johnson DW, Irish AB; Omega-3 Fatty Acids (Fish Oils) and Aspirin in Vascular Access Outcomes in Renal Disease (FAVOURED) Study Collaborative Group.

PLoS One. 2019 Mar 26;14(3):e0213274. doi: 10.1371/journal.pone.0213274. eCollection 2019.


Chronic Kidney Disease and Pulse Wave Velocity: A Narrative Review.

Lioufas N, Hawley CM, Cameron JD, Toussaint ND.

Int J Hypertens. 2019 Feb 17;2019:9189362. doi: 10.1155/2019/9189362. eCollection 2019. Review.


Effect of centre- and patient-related factors on uptake of haemodiafiltration in Australia and New Zealand: A cohort study using ANZDATA.

Mac K, Hedley J, Kelly PJ, Lee VW, Agar JWM, Hawley CM, Johnson DW, See EJ, Polkinghorne KR, Rabindranath KS, Sud K, Webster AC.

Nephrology (Carlton). 2019 Mar 5. doi: 10.1111/nep.13574. [Epub ahead of print]


'Knowledge is power': A framework for partnering with consumers in developing and delivering a scientific meeting in nephrology.

Duncanson E, Dansie K, Gutman T, Tong A, Howell M, Jesudason S, Reidlinger D, Williamson A, Scholes-Robertson N, Murphy L, Hawley CM, Craig JC, Johnson DW, McDonald S.

Nephrology (Carlton). 2019 Jan 29. doi: 10.1111/nep.13570. [Epub ahead of print]


Incremental and twice weekly haemodialysis in Australia and New Zealand.

Wolley MJ, Hawley CM, Johnson DW, Marshall MR, Roberts MA.

Nephrology (Carlton). 2019 Jan 10. doi: 10.1111/nep.13556. [Epub ahead of print]


A novel approach to fuel biomass sampling for 3D fuel characterization.

Hawley CM, Loudermilk EL, Rowell EM, Pokswinski S.

MethodsX. 2018 Nov 17;5:1597-1604. doi: 10.1016/j.mex.2018.11.006. eCollection 2018.


Perioperative outcomes and risk assessment in dialysis patients: current knowledge and future directions.

Palamuthusingam D, Johnson DW, Hawley CM, Pascoe E, Sivalingam P, Fahim M.

Intern Med J. 2019 Jun;49(6):702-710. doi: 10.1111/imj.14168. Review.


End-Stage Kidney Disease following Surgical Management of Kidney Cancer.

Ellis RJ, Edey DP, Del Vecchio SJ, McStea M, Campbell SB, Hawley CM, Johnson DW, Morais C, Jordan SJ, Francis RS, Wood ST, Gobe GC; Cancer Alliance Queensland.

Clin J Am Soc Nephrol. 2018 Nov 7;13(11):1641-1648. doi: 10.2215/CJN.06560518. Epub 2018 Sep 28.


Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.

Lo C, Toyama T, Wang Y, Lin J, Hirakawa Y, Jun M, Cass A, Hawley CM, Pilmore H, Badve SV, Perkovic V, Zoungas S.

Cochrane Database Syst Rev. 2018 Sep 24;9:CD011798. doi: 10.1002/14651858.CD011798.pub2. Review.


Early Peritoneal Dialysis Technique Failure: Review.

Cho Y, See EJ, Htay H, Hawley CM, Johnson DW.

Perit Dial Int. 2018 Sep-Oct;38(5):319-327. doi: 10.3747/pdi.2018.00017. Review.


Patient survival on haemodiafiltration and haemodialysis: a cohort study using the Australia and New Zealand Dialysis and Transplant Registry.

See EJ, Hedley J, Agar JWM, Hawley CM, Johnson DW, Kelly PJ, Lee VW, Mac K, Polkinghorne KR, Rabindranath KS, Sud K, Webster AC.

Nephrol Dial Transplant. 2019 Feb 1;34(2):326-338. doi: 10.1093/ndt/gfy209.


Associations Between Peritoneal Glucose Exposure, Glucose Degradation Product Exposure, and Peritoneal Membrane Transport Characteristics in Peritoneal Dialysis Patients: Secondary Analysis of the balANZ Trial.

Nataatmadja MS, Johnson DW, Pascoe EM, Darssan D, Hawley CM, Cho Y; balANZ Trial Investigators.

Perit Dial Int. 2018 Sep-Oct;38(5):349-355. doi: 10.3747/pdi.2017.00223. Epub 2018 Aug 7.


Outcomes of cinacalcet withdrawal in Australian dialysis patients.

Ruderman I, Holt SG, Kirkland GS, Maslen S, Hawley CM, Oliver V, Krishnasamy R, Gray NA, Talaulikar GS, Nelson CL, Rajaram Y, Gock H, Au E, Elder GJ, Mainra R, Toussaint ND.

Intern Med J. 2019 Jan;49(1):48-54. doi: 10.1111/imj.14036.


Predictors of new-onset chronic kidney disease in patients managed surgically for T1a renal cell carcinoma: An Australian population-based analysis.

Ahn T, Ellis RJ, White VM, Bolton DM, Coory MD, Davis ID, Francis RS, Giles GG, Gobe GC, Hawley CM, Johnson DW, Marco DJT, McStea M, Neale RE, Pascoe EM, Wood ST, Jordan SJ; IMPROVE investigators.

J Surg Oncol. 2018 Jun;117(7):1597-1610. doi: 10.1002/jso.25037. Epub 2018 May 22.


Design and methods of the REMOVAL-HD study: a tRial Evaluating Mid cut-Off Value membrane clearance of Albumin and Light chains in HaemoDialysis patients.

Krishnasamy R, Hawley CM, Jardine MJ, Roberts MA, Cho YJ, Wong MG, Heath A, Nelson CL, Sen S, Mount PF, Pascoe EM, Darssan D, Vergara LA, Paul-Brent PA, Toussaint ND, Johnson DW, Hutchison CA.

BMC Nephrol. 2018 Apr 17;19(1):89. doi: 10.1186/s12882-018-0883-8.


Report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop on Establishing a Core Outcome Measure for Hemodialysis Vascular Access.

Viecelli AK, Tong A, O'Lone E, Ju A, Hanson CS, Sautenet B, Craig JC, Manns B, Howell M, Chemla E, Hooi LS, Johnson DW, Lee T, Lok CE, Polkinghorne KR, Quinn RR, Vachharajani T, Vanholder R, Zuo L, Hawley CM; SONG-HD Vascular Access Workshop Investigators.

Am J Kidney Dis. 2018 May;71(5):690-700. doi: 10.1053/j.ajkd.2017.12.003. Epub 2018 Feb 23. Review.


Scope and Consistency of Outcomes Reported in Randomized Trials Conducted in Adults Receiving Hemodialysis: A Systematic Review.

Sautenet B, Tong A, Williams G, Hemmelgarn BR, Manns B, Wheeler DC, Tugwell P, van Biesen W, Winkelmayer WC, Crowe S, Harris T, Evangelidis N, Hawley CM, Pollock C, Johnson DW, Polkinghorne KR, Howard K, Gallagher MP, Kerr PG, McDonald SP, Ju A, Craig JC.

Am J Kidney Dis. 2018 Jul;72(1):62-74. doi: 10.1053/j.ajkd.2017.11.010. Epub 2018 Feb 21.


Omega-3 Polyunsaturated Fatty Acid Supplementation to Prevent Arteriovenous Fistula and Graft Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Viecelli AK, Irish AB, Polkinghorne KR, Hawley CM, Johnson DW, Mori TA, Pascoe EM, Strippoli GFM, Lok CE, Palmer SC.

Am J Kidney Dis. 2018 Jul;72(1):50-61. doi: 10.1053/j.ajkd.2017.11.017. Epub 2018 Feb 12.


Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD).

Wong ATY, Mannix C, Grantham JJ, Allman-Farinelli M, Badve SV, Boudville N, Byth K, Chan J, Coulshed S, Edwards ME, Erickson BJ, Fernando M, Foster S, Haloob I, Harris DCH, Hawley CM, Hill J, Howard K, Howell M, Jiang SH, Johnson DW, Kline TL, Kumar K, Lee VW, Lonergan M, Mai J, McCloud P, Peduto A, Rangan A, Roger SD, Sud K, Torres V, Vilayur E, Rangan GK.

BMJ Open. 2018 Jan 21;8(1):e018794. doi: 10.1136/bmjopen-2017-018794. Erratum in: BMJ Open. 2018 Aug 5;8(8):e018794corr1.


Comparison of graft and patient outcomes following kidney transplantation in extended hour and conventional haemodialysis patients.

See EJ, Hawley CM, Cho Y, Toussaint ND, Agar JW, Pascoe EM, Lim WH, Francis RS, Collins MG, Johnson DW.

Nephrology (Carlton). 2019 Jan;24(1):111-120. doi: 10.1111/nep.13221.


Risk Predictors and Causes of Technique Failure Within the First Year of Peritoneal Dialysis: An Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) Study.

See EJ, Johnson DW, Hawley CM, Pascoe EM, Badve SV, Boudville N, Clayton PA, Sud K, Polkinghorne KR, Borlace M, Cho Y.

Am J Kidney Dis. 2018 Aug;72(2):188-197. doi: 10.1053/j.ajkd.2017.10.019. Epub 2017 Dec 23.


Vascular Access Outcomes Reported in Maintenance Hemodialysis Trials: A Systematic Review.

Viecelli AK, O'Lone E, Sautenet B, Craig JC, Tong A, Chemla E, Hooi LS, Lee T, Lok C, Polkinghorne KR, Quinn RR, Vachharajani T, Vanholder R, Zuo L, Irish AB, Mori TA, Pascoe EM, Johnson DW, Hawley CM.

Am J Kidney Dis. 2018 Mar;71(3):382-391. doi: 10.1053/j.ajkd.2017.09.018. Epub 2017 Dec 6.


Carvedilol and Cardiac Biomarkers in Dialysis Patients: Secondary Analysis of a Randomized Controlled Trial.

Roberts MA, Darssan D, Badve SV, Carroll RP, Fahim MA, Haluska BA, Hawley CM, Isbel NM, Marshall MR, Pascoe EM, Pedagogos E, Pilmore HL, Snelling P, Stanton T, Tan KS, Tonkin AM, Vergara LA, Ierino FL.

Kidney Blood Press Res. 2017;42(6):1033-1044. doi: 10.1159/000485589. Epub 2017 Dec 4.


Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney Transplantation: A Population Cohort Study.

Lim WH, Johnson DW, Hawley CM, Pascoe E, Wong G.

Am J Kidney Dis. 2018 Jan;71(1):102-111. doi: 10.1053/j.ajkd.2017.08.018. Epub 2017 Nov 28.


Factors associated with acutely elevated serum creatinine following radical tumour nephrectomy: the Correlates of Kidney Dysfunction-Tumour Nephrectomy Database study.

Ellis RJ, Del Vecchio SJ, Ng KL, Dimeski G, Pascoe EM, Hawley CM, Johnson DW, Vesey DA, Coombes JS, Morais C, Francis RS, Wood ST, Gobe GC.

Transl Androl Urol. 2017 Oct;6(5):899-909. doi: 10.21037/tau.2017.08.15.


The pathogenesis of hemodialysis vascular access failure and systemic therapies for its prevention: Optimism unfulfilled.

Viecelli AK, Mori TA, Roy-Chaudhury P, Polkinghorne KR, Hawley CM, Johnson DW, Pascoe EM, Irish AB.

Semin Dial. 2018 May;31(3):244-257. doi: 10.1111/sdi.12658. Epub 2017 Nov 26. Review.


Practice of Peritoneal Dialysis Catheter Flushing in Australia and New Zealand: Multi-Center Cross-Sectional Survey.

Cho Y, Boudville N, Palmer SC, Chow JSF, Hawley CM, Jose MD, MacGinley R, Huang L, Moodie JA, Nguyen T, Robison L, Wong J, Johnson DW.

Perit Dial Int. 2018 Mar-Apr;38(2):98-103. doi: 10.3747/pdi.2017.00108. Epub 2017 Nov 2.



See EJ, Johnson DW, Hawley CM, Pascoe EM, Darssan D, Clayton PA, Borlace M, Badve SV, Sud K, Boudville NC, Cho Y.

Perit Dial Int. 2017 Sep 28. pii: pdi.2017.00029. doi: 10.3747/pdi.2017.00029. [Epub ahead of print]


Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD.

Krishnasamy R, Tan SJ, Hawley CM, Johnson DW, Stanton T, Lee K, Mudge DW, Campbell S, Elder GJ, Toussaint ND, Isbel NM.

BMC Nephrol. 2017 Sep 4;18(1):281. doi: 10.1186/s12882-017-0705-4.


Parathyroid hormone targets in chronic kidney disease and managing severe hyperparathyroidism.

Hawley CM, Holt SG.

Nephrology (Carlton). 2017 Mar;22 Suppl 2:47-50. doi: 10.1111/nep.13029. Review.


Association Between Peritoneal Glucose Exposure and Peritonitis in Peritoneal Dialysis Patients: The balANZ Trial.

Nataatmadja M, Cho Y, Pascoe EM, Darssan D, Hawley CM, Johnson DW; balANZ Trial Investigators.

Perit Dial Int. 2017 Jul-Aug;37(4):407-413. doi: 10.3747/pdi.2016.00263. Epub 2017 Apr 13. Erratum in: Perit Dial Int. 2017 Jul-Aug;37(4):486.


The SIESTA Trial: A Randomized Study Investigating the Efficacy, Safety, and Tolerability of Acupressure versus Sham Therapy for Improving Sleep Quality in Patients with End-Stage Kidney Disease on Hemodialysis.

Shen K, Cho Y, Pascoe EM, Hawley CM, Oliver V, Hughes KM, Baer R, Frazier J, Jarvis E, Tan KS, Liu X, Gobe G, Johnson DW.

Evid Based Complement Alternat Med. 2017;2017:7570352. doi: 10.1155/2017/7570352. Epub 2017 Feb 21.


Association of Socio-Economic Position with Technique Failure and Mortality in Australian Non-Indigenous Peritoneal Dialysis Patients.

Chan S, Cho Y, Koh YH, Boudville NC, Clayton PA, McDonald SP, Pascoe EM, Francis RS, Mudge DW, Borlace M, Badve SV, Sud K, Hawley CM, Johnson DW.

Perit Dial Int. 2017 Jul-Aug;37(4):397-406. doi: 10.3747/pdi.2016.00209. Epub 2017 Feb 9.


Effect of Fish Oil Supplementation and Aspirin Use on Arteriovenous Fistula Failure in Patients Requiring Hemodialysis: A Randomized Clinical Trial.

Irish AB, Viecelli AK, Hawley CM, Hooi LS, Pascoe EM, Paul-Brent PA, Badve SV, Mori TA, Cass A, Kerr PG, Voss D, Ong LM, Polkinghorne KR; Omega-3 Fatty Acids (Fish Oils) and Aspirin in Vascular Access Outcomes in Renal Disease (FAVOURED) Study Collaborative Group.

JAMA Intern Med. 2017 Feb 1;177(2):184-193. doi: 10.1001/jamainternmed.2016.8029.


Teaching peritoneal dialysis in Australia: An opportunity for improvement.

Boudville N, Cho Y, Equinox KL, Figueiredo AE, Hawley CM, Howard K, Johnson DW, Jose M, Lee A, Maley MA, Moodie JA, Pascoe EM, Steiner GZ, Tomlins M, Voss D, Chow J.

Nephrology (Carlton). 2018 Mar;23(3):259-263. doi: 10.1111/nep.12992.


Early and Late Patient Outcomes in Urgent-Start Peritoneal Dialysis.

See EJ, Cho Y, Hawley CM, Jaffrey LR, Johnson DW.

Perit Dial Int. 2017 Jul-Aug;37(4):414-419. doi: 10.3747/pdi.2016.00158. Epub 2016 Dec 22.


Representativeness of Honeypot Trial Participants to Australasian PD Patients.

HONEYPOT Trial Writing Committee, Zhang L, Badve SV, Pascoe EM, Beller E, Cass A, Clark C, de Zoysa J, Isbel NM, Liu X, McTaggart S, Morrish AT, Playford G, Scaria A, Snelling P, Vergara LA, Hawley CM, Johnson DW; HONEYPOT Study Collaborative Group.

Perit Dial Int. 2017 Sep-Oct;37(5):516-522. doi: 10.3747/pdi.2016.00065. Epub 2016 Dec 1.


Temporal Changes in Deceased Kidney Donor Characteristics in Australia.

Chan S, Campbell SB, Clayton PA, Mudge DW, Cho Y, Hawley CM, Johnson DW, Francis RS.

Transplant Direct. 2016 Oct 25;2(11):e112. eCollection 2016 Nov.


An update on bone imaging and markers in chronic kidney disease.

Krishnasamy R, Hawley CM, Johnson DW.

Expert Rev Endocrinol Metab. 2016 Nov;11(6):455-466. doi: 10.1080/17446651.2016.1239527. Epub 2016 Sep 28.


Mammalian Target of Rapamycin Inhibitors and Clinical Outcomes in Adult Kidney Transplant Recipients.

Badve SV, Pascoe EM, Burke M, Clayton PA, Campbell SB, Hawley CM, Lim WH, McDonald SP, Wong G, Johnson DW.

Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1845-1855. doi: 10.2215/CJN.00190116. Epub 2016 Jul 21.


Updates on baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study.

Viecelli AK, Pascoe EM, Polkinghorne KR, Hawley CM, Paul-Brent PA, Badve SV, Cass A, Johnson DW, Kerr PG, Mori TA, Scaria A, Hooi LS, Ong LM, Irish AB; FAVOURED study team.

Nephrology (Carlton). 2017 Oct;22(10):823-824. doi: 10.1111/nep.12823. No abstract available.


Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.

Gummer J, Trengove R, Pascoe EM, Badve SV, Cass A, Clarke P, McDonald SP, Morrish AT, Pedagogos E, Perkovic V, Reidlinger D, Scaria A, Walker R, Vergara LA, Hawley CM, Johnson DW, Olynyk JK, Ferrari P; HERO Study Collaborative Group.

Nephrology (Carlton). 2017 Jul;22(7):548-554. doi: 10.1111/nep.12815.


Long-term outcomes of end-stage kidney disease for patients with lupus nephritis.

Zhang L, Lee G, Liu X, Pascoe EM, Badve SV, Boudville NC, Clayton PA, Hawley CM, Kanellis J, McDonald SP, Peh CA, Polkinghorne KR, Johnson DW.

Kidney Int. 2016 Jun;89(6):1337-45. doi: 10.1016/j.kint.2016.02.014. Epub 2016 Apr 8.


The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis.

Badve SV, Palmer SC, Strippoli GFM, Roberts MA, Teixeira-Pinto A, Boudville N, Cass A, Hawley CM, Hiremath SS, Pascoe EM, Perkovic V, Whalley GA, Craig JC, Johnson DW.

Am J Kidney Dis. 2016 Oct;68(4):554-563. doi: 10.1053/j.ajkd.2016.03.418. Epub 2016 Apr 30. Review.


Supplemental Content

Loading ...
Support Center